Obermatt

Sonic

ASX:SHL · AU000000SHL7
Health Care Providers & ServicesX-Large

360

36
EV / EBIT52
Price / Owner Earnings25
Owner Earnings Yield52
Dividend Yield95
Price/Sales75
EV / Gross Profit55
Price/Book67
Return on Capital50
Cash Return on Capital45
Return on Equity53
EBIT Margin67
Gross Profitability29
Cash Conversion55
Accruals17
Owner Earnings Margin55
Sales growth68
Profit Growth89
Long-Term EPS Growth53
Owner Earnings Growth20
Reinvestment89
Price momentum30
Debt load28
Refinancing53
Debt Payback16
Liquidity45
Analyst ratings21
Opinion Changes37
Price Target Upside55
Market mood67
Value Creation10/20creating some value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Sonic clears its cost of capital, but the record is mixed across the five tests. Real value creation, just not yet consistent.

Profile

CountryAustralia
IndustryHealth Care Providers & Services
SizeX-Large
TypePublic Company
ExchangeASX
Founded1934
Employees999
ISINAU000000SHL7
Last UpdateApr 2, 2026
Themes
Chronic DiseasesImmunologyHematologyHealth DiagnosticsGeneticsDermatologyInfectious DiseasesOncologyHealth CareMedical

Description

Sonic Healthcare Limited is a provider of medical diagnostic services, operates through a network of local laboratories and various subsidiaries across multiple geographical regions. The company operates based on a management philosophy known as Medi…

Analysis

Middle-of-the-road

Sonic Healthcare Limited sits in the middle of our grid: average quality, average price, no obvious signal in either direction.

On valuation, the picture is expensive. The owner-earnings multiple stands at 27.1×; owner earnings: the cash an owner could take out each year. The implied growth embedded in that price is around 10% a year, against analyst forecasts of 12%. The price, in other words, assumes less than the experts do.

Growth is moderate; the safety picture is adequate. The company scores 10/20 on our value-creation score: creating some value.

No flags apply to this company at this time: accounts, balance sheet, and cash quality all pass. A clean bill of health is meaningful, not just the absence of a warning. This analysis describes numbers; it is not investment advice.

360° rank · history

1007550250
85
2023202420252026

All-time high

90

Mar 2026

All-time low

7

Jun 2024

Average rank

49

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
75
67
57
55
Price/Earnings
50
38
48
63
Price/Book
67
56
49
51
Dividend Yield
95
98
88
80
Value (overall)
84
92
63
59

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Sonic with its peers
Integral Diagnostics
ASX:IDX
45
CountryAustralia
IndustryHealth Care Providers & Services
SizeMedium
Full Stock Analysis →
Healius
ASX:HLS
20
CountryAustralia
IndustryHealth Care Providers & Services
SizeMedium
Full Stock Analysis →
Australian Clinical Labs
ASX:ACL
65
CountryAustralia
IndustryHealth Care Providers & Services
SizeMedium
Full Stock Analysis →
M3
TYO:2413
87
CountryJapan
IndustryHealth Care Technology
SizeLarge
Full Stock Analysis →
Sinovac Biotech
NSQ:SVA
CountryChina
IndustryBiotechnology
SizeMedium
Full Stock Analysis →
Sysmex
TYO:6869
77
CountryJapan
IndustryHealth Care Equipment & Supplies
SizeLarge
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →